← Leaderboards
Alan Marshall Miller
Tulane University Of Louisiana
$44,720
Attributed
$44,720
Total exposure
6
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $7.4M · FY2006–07$10M$7.5M$5M$2.5M$0
'06
'07
Funding mix
By agency
NIH$7,989,198 · 7
By mechanism
P51$7,944,478 · 1
M01$44,720 · 6
Top collaborators
No co-investigators on record.
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Patricia S Braly$22,399
- Ellen L Zakris$642,522
- Paul O Schwarzenberger$3,319,899
- Pui Chun Cheng$48,251
- Juan J. L. Lertora$4,837,795
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectHuman Therapy EvaluationClinical ResearchNeoplasm /Cancer ChemotherapyCis Platinum CompoundPaclitaxelNeoplasm /Cancer Radiation TherapyFemaleCombination Cancer TherapyAntineoplasticsEtoposideCarboplatinCell TransplantationCervix NeoplasmsDietary IronDiet TherapyDrug Administration Rate /DurationErythropoietinNutrition Related TagOvary NeoplasmsSmall Cell Lung CancerClinical Trial Phase ICd34 MoleculeNonsmall Cell Lung Cancer
Grant awards (11)
TULANE NATINAL PRIMATE RESEARCH CENTER$530,303
P51 · FY2007 · RR · contact PI
TULANE NATINAL PRIMATE RESEARCH CENTER$7,414,175
P51 · FY2006 · RR · contact PI
SWOG 9713:CISPLATIN &ETOPOSIDE &CONCURRENT RADIOTHERAPY FOR SMALL C$0
M01 · FY2001 · RR
PACLITAXEL (12 VS 3 MONTHS) FOR OVARIAN CANCER$0
M01 · FY2001 · RR
ERYTHROPOIETIN + RADIATION/CISPLATIN IN CERVIX CANCINOMA$0
M01 · FY2001 · RR
CD34 SELECTED PERIPHERAL BLOOD PROGENITOR CELLS W/ IMMUNOBLATION$11,180
M01 · FY2000 · RR
SWOG JBR10:STUDY OF ADJUVANT CHEMOTHERAPY, VINORELBINE &CISPLATIN, L$11,180
M01 · FY2000 · RR
SWOG S9704:COMPARING HIGH DOSE CHEMORADIOTHERAPY &AUTOLOGOUS CELL TR$11,180
M01 · FY2000 · RR
SWOG 9713:CISPLATIN &ETOPOSIDE &CONCURRENT RADIOTHERAPY FOR SMALL C$11,180
M01 · FY2000 · RR
ERYTHROPOIETIN + RADIATION/CISPLATIN IN CERVIX CANCINOMA$0
M01 · FY2000 · RR
PACLITAXEL (12 VS 3 MONTHS) FOR OVARIAN CANCER$0
M01 · FY2000 · RR